×
畅享IT
    信息化规划
    IT总包
    供应商选型
    IT监理
    开发维护外包
    评估维权
客服电话
400-698-9918
当前位置:畅享论坛 >  行业关注  >  医药  > 正文
发帖
回复
(共 6 条) 上一页 1 下一页
查看: 1747|回复: 6

[分享]2010年中国十大医药制造公司研究报告

[复制链接]

等级:试用期
行业:
职能部门:
城市:
金币:539

Top 10 Companies in the Hospital Pharmaceutical in China From Business insight


Table of Contents
About the author 2
Disclaimer  2
_executive summary 14
Industry overview 14
Pfizer  14
AstraZeneca  15
Bayer  16
Sanofi-Aventis  16
Roche  17
Js Yangzijiang Fty 17
Merck & Co.  18
Kelun Pharmaceutical 19
Shandong Qilu  19
GlaxoSmithKline (GSK) 20
Chapter 1    Scope and methodology 21
Scope  21
Methodology  21
IMS caveat  22
Chapter 2 Industry overview 23
Summary  23
Introduction  23
Key market drivers and resistors 24
Market drivers  24
Market resistors  25
The Chinese healthcare system 26
Chinese drug approval system 28
Chinese drug regulatory system 29
Intellectual property protection 31 
4
 
Pricing and reimbursement 33
Drug distribution system  35
Recent healthcare reforms and their impact on the Chinese pharmaceutical industry 37
Generics market in China 39
Biotech developments in China 41
Improving scientific base  43
Chinese biosimilar market  43
Major biosimilars in China  45
Traditional Chinese medicines (TCMs) 46
Market dynamics  47
Chinese pharmaceutical market size and growth 47
Leading therapeutic areas 48
Competitive landscape  49
Competitive positioning of the top 10 companies 49
Chapter 3     Pfizer 52
Summary  52
Company overview 53
Therapeutic area focus 54
Marketed product portfolio 55
Research and development 56
Growth strategies 58
Co-promotion of Takeda's Actos 58
Strategic partnership with BMP Sunstone to co-promote Depo-Provera 58
Pfizer's recent developments in the R&D sector 58
SWOT analysis  60
Chapter 4   AstraZeneca 61
Summary  61
Company overview 62
Therapeutic area focus 62
Marketed product portfolio 63
Research and development 64 
5
 
Growth strategies 65
Establishment of API production, medicine formulation and packaging sites in China 65
R&D investments in China 66
AstraZeneca's new site in Zhangjiang, High-Tech Park 66
SWOT analysis  67
Chapter 5    Bayer 68
Summary  68
Company overview 69
Therapeutic area focus 69
Marketed product portfolio 70
Research and development 71
Growth strategies 72
Establishment of Bayer-Tsinghua Research Center 72
Partnership with the People's Liberation Army General Hospital 72
Strategic acquisitions and in-licensing of products in China 73
SWOT analysis  74
Chapter 6    Sanofi-Aventis 75
Summary  75
Company overview 76
Therapeutic area focus 76
Marketed product portfolio 77
Research and development 79
Growth strategies 81
Sanofi-Aventis's alliances and partnerships in China 81
Increasing R&D and expanding manufacturing capabilities in China 81
SWOT analysis  82
Chapter 7    Roche 83
Summary  83
Company overview 83
Therapeutic area focus 84 
6
 
Marketed product portfolio 85
Research and development 86
Growth strategies 88
Extensive R&D activity at its center in Shanghai 88
Establishment of manufacturing units in China 88
SWOT analysis  89
Chapter 8   Js.Yangzijiang Fty 90
Summary  90
Company overview 91
Therapeutic area focus 91
Marketed product portfolio 92
Research and development 92
SWOT analysis  93
Chapter 9   Merck & Co. 94
Summary  94
Company overview 95
Therapeutic area focus 95
Marketed product portfolio 96
Research and development 97
Growth strategies 98
Joint venture with Sinopharm to market human papillomavirus vaccines (HPV) 98
Establishment of Merck Serono's R&D center in China 99
SWOT analysis  99
Chapter 10   Kelun group 100
Summary  100
Company overview 101
Therapeutic area focus 101
Marketed product portfolio 102
Research and development 103
SWOT analysis  104
Chapter 11   Shandong Qilu Fty 105 
7
 
Summary  105
Company overview 106
Therapeutic area focus 106
Marketed product portfolio 107
Research and development 108
SWOT analysis  109
Chapter 12    GlaxoSmithKline (GSK) 110
Summary  110
Company overview 111
Therapeutic area focus 112
Marketed product portfolio 113
Research and development 114
Growth strategies 115
Joint venture with Shenzhen Neptunus to develop influenza vaccines 115
Joint venture with Jiangsu Walvax to develop pediatric vaccines 115
China to be GSK's center for global R&D in the near future 116
Drapolene launched in China 116
SWOT analysis  117
Chapter 13   11- 15 companies 118
Novartis  118
Company overview  118
Therapeutic area focus  118
Marketed products  120
Research and development 120
Js.L.Y.G. Hengrui 121
Company overview  121
Therapeutic area focus  121
Marketed products  123
Research and development 123
Hlj.Haerbin Pharmaceuticals 124
Company overview  124 
8
 
Therapeutic focus  124
Marketed products  126
Research and development 126
Fresenius  127
Company overview  127
Therapeutic focus  127
Marketed products  129
Research and development 130
Novo Nordisk  130
Company overview  130
Therapeutic focus  130
Marketed products  131
Research and development 132
Appendix 133
Anatomical therapeutic chemical (ATC) classification 133
A: Alimentary tract and metabolism 133
B: Blood and blood-forming organs 133
C: Cardiovascular system 133
D: Dermatologicals  133
G: Genitourinary system and sex hormones 133
H: Systemic hormonal preparations 133
J: General anti-infectives systemic 134
K: Hospital solutions  134
L: Antineoplastic and immunomodulating agents 134
M: Musculo-skeletal system 134
N: Nervous system  134
P: Parasitology  134
R: Respiratory system  134
S: Sensory organs  135 
9
 
T: Diagnostic agents  135
V: Various  135
Glossary  136



本文是金币贴,价值 1 个金币,需要购买后才可以看到。(仅需要购买一次) (已有 40 人购买) 点击购买


畅享论坛提示:看帖后顺手回帖,是对辛苦发帖者的鼓励,是美德。

查阅更多相关主题的帖子: 医药制造 医药厂商

等级:试用期
行业:医疗/护理/保健/卫生
职能部门:市场管理
城市:芜湖市
金币:30
 发表于 2010/11/3 8:12:22 | 圈子 | 发送站内信 | 加为好友 | 邀请加入圈子
top第1楼


2010技术大会将于12月1日-2日在上海举行,敬请关注。
立即注册以获得更多购票优惠。


SAP顶尖的技术精英和行业专家将与您共同分享产品路线、最佳实践、演示、技巧和诀窍、代码样本以及实践上机操作。


大会内容纲要

等级:经理
行业:
职能部门:综合经营/企业管理
城市:北京
金币:488
 发表于 2010/11/3 9:39:53 | 圈子 | 发送站内信 | 加为好友 | 邀请加入圈子
top第2楼
支持

等级:高级经理
行业:
职能部门:
城市:上海
金币:20269
 发表于 2010/11/3 21:04:23 | 圈子 | 发送站内信 | 加为好友 | 邀请加入圈子
top第3楼

等级:试用期
行业:公共服务(党政机关)
职能部门:战略与业务发展
城市:北京
金币:41
 发表于 2011/9/15 16:26:33 | 圈子 | 发送站内信 | 加为好友 | 邀请加入圈子
top第4楼

支持


等级:试用期
行业:
职能部门:
城市:北京
金币:239
 发表于 2012/6/12 13:12:06 | 圈子 | 发送站内信 | 加为好友 | 邀请加入圈子
top第5楼
感谢分享!

等级:经理
行业:教育
职能部门:其他
城市:南昌市
金币:84
 发表于 2012/7/2 12:03:17 | 圈子 | 发送站内信 | 加为好友 | 邀请加入圈子
top第6楼
(共 6 条) 上一页 1 下一页
您还未登录,不能对文章发表评论!请先登录
2020-07-15 05:01:51 335/2020-07-15 05:01:51 366/2020-07-15 05:01:51 413